{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:06:28Z","timestamp":1790975188017,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.bbrc.2004.04.067","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:53:05Z","timestamp":1082713985000},"page":"562-570","source":"Crossref","is-referenced-by-count":103,"title":["Incorporation of biodegradable nanoparticles into human airway epithelium cells\u2014in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases"],"prefix":"10.1016","volume":"318","author":[{"given":"M","family":"Brzoska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Coester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Loitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.O.F","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.v","family":"Mallinckrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2004.04.067_BIB1","first-page":"217","article-title":"Evaluation of nanoparticles as drug-delivery systems II: comparison of the body distibution of nanoparticles with the body distribution of microspheres (diameter >1\u03bcm), liposomes, and emulsions","volume":"58","author":"Kreuter","year":"1983","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1128\/AAC.40.6.1467","article-title":"Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes\/macrophages in vitro","volume":"40","author":"Bender","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00034983.1992.11812629","article-title":"Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani","volume":"86","author":"Gaspar","year":"1992","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB4","first-page":"51","article-title":"Antisense phosphorothioat-oligonukleotide: inhibitoren der translation in vivo","volume":"2","author":"Bodner","year":"1991","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1015871809313","article-title":"Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides","volume":"9","author":"Chavany","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/7374","article-title":"Gene therapy for peanut allergy","volume":"5","author":"Moffatt","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/7385","article-title":"Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy","volume":"5","author":"Roy","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-3659(03)00302-X","article-title":"Human serum albumin\u2013polyethylenimine nanoparticles for gene delivery","volume":"92","author":"Rhaese","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB9","first-page":"893","article-title":"Enhancement of transfection by physical concentration of DNA at the cell surface","volume":"18","author":"Luo","year":"2000","journal-title":"Biotechnology"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/sj.gt.3301318","article-title":"Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles","volume":"7","author":"Cohen","year":"2000","journal-title":"Gene Therapy"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB11","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.4049\/jimmunol.164.12.6313","article-title":"Genetic immunization with lung-targeting macroaggregated polyethyleneimine\u2013albumin conjugates elicits combined systemic an mucosal immune responses","volume":"164","author":"Orson","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.gt.3301666","article-title":"Gene delivery to the lung using protein\/polyethyleneimine\/plasmid complexes","volume":"9","author":"Orson","year":"2002","journal-title":"Gene Therapy"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1089\/hum.1998.9.12-1709","article-title":"Controlled gene delivery by DNA-gelatin nanospheres","volume":"9","author":"Truong-Le","year":"1998","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/38410","article-title":"Gene therapy\u2014promises, problems and prospects","volume":"389","author":"Verma","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1172\/JCI6330","article-title":"Status of gene therapy for cystic fibrosis lung disease","volume":"103","author":"Boucher","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-132-8-200004180-00008","article-title":"Gene therapy for lung disease: hype or hope?","volume":"132","author":"Albelda","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1089\/hum.1996.7.12-1437","article-title":"Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery","volume":"7","author":"Plank","year":"1996","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/abbi.1998.0975","article-title":"Gene transfer by DNA gelatin nanospheres","volume":"361","author":"Truong-Le","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0005-2736(99)00238-2","article-title":"Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum","volume":"1463","author":"Simoes","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB20","unstructured":"A.R. Bender, Thesis: Nanopartikel und Liposomen als Tr\u00e4gersysteme f\u00fcr antivirale Wirkstoffe gegen HIV: Entwicklung und pr\u00e4klinische Testung in der Zellkultur, 1997"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1165\/ajrcmb.14.5.8624246","article-title":"Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5","volume":"14","author":"Noah","year":"1996","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/JVI.71.1.398-404.1997","article-title":"Adenovirus infection stimulates the Raf\/MAPK signaling pathway and induces interleukin-8 expression","volume":"71","author":"Bruder","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01797773","article-title":"A serum free method for culturing normal human bronchial epithelial cells at clonal density","volume":"9","author":"Lechner","year":"1985","journal-title":"J. Tissue Cult. Methods"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB24","unstructured":"Courveur, Patrick, Speiser, P.P., patent number 4.329.332 (1982)"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB25","first-page":"2","article-title":"Controlled drug delivery with nanoparticles: current possibilities and future trends","volume":"41","author":"Courveur","year":"1995","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jps.2600710717","article-title":"Toxicity of polyalkylcyanoacrylate nanoparticles: II. Doxorubicin-loaded nanoparticles","volume":"71","author":"Courveur","year":"1982","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1165\/ajrcmb.19.2.3053","article-title":"Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation","volume":"19","author":"Black","year":"1998","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(99)00370-1","article-title":"Desolvation process and surface characterization of protein nanoparticles","volume":"194","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5173(99)00420-2","article-title":"Desolvation process and surface characteristics of HSA-nanoparticles","volume":"196","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/026520400288427","article-title":"Gelatin nanoparticles by two step desolvation\u2014a new preparation method, surface modifications and cell uptake","volume":"17","author":"Coester","year":"2000","journal-title":"J. Microencapsulat."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB31","first-page":"1130","article-title":"A human respiratory-tissue organ culture incorporating an air interface","volume":"153","author":"Jackson","year":"1996","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB32","first-page":"L713","article-title":"Differentiated structure and function of cultures from human tracheal epithelium","volume":"262","author":"Yamaya","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1183\/09031936.93.04020210","article-title":"Contribution of in vitro culture methods for respiratory epithelial cells to the study of the physiology of the respiratory tract","volume":"4","author":"Jorissen","year":"1991","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/ajrcmb.10.1.7507342","article-title":"CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells","volume":"10","author":"Cozens","year":"1994","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB35","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1183\/09031936.96.09091913","article-title":"Bacterial-induced release of inflammatory mediators by bronchial epithelial cells","volume":"9","author":"Khair","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/bbrc.2000.3504","article-title":"Reactive oxygen intermediates are involved in IL-8 production induced by hyperosmotic stress in human bronchial epithelial cells","volume":"276","author":"Loitsch","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB37","first-page":"242","article-title":"Evaluation of nanoparticles as drug-delivery systems iii: materials, stability, toxicity, possibilities of targeting, and use","volume":"58","author":"Kreuter","year":"1983","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-5173(92)90210-S","article-title":"Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length","volume":"84","author":"Lherm","year":"1992","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bbrc.2004.04.067_BIB39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10611860290022660","article-title":"Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells","volume":"10","author":"Merodio","year":"2002","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.bbrc.2004.04.067_BIB40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1015885814417","article-title":"Liposomes and nanoparticles in the treatment of intracellular bacterial infections","volume":"8","author":"Courveur","year":"1991","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2004.04.067_BIB41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/meth.1999.0786","article-title":"Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers","volume":"18","author":"Zimmer","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2004.04.067_BIB42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0939-6411(00)00068-0","article-title":"Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid","volume":"49","author":"Langer","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbrc.2004.04.067_BIB43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-5173(99)00409-3","article-title":"Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA)","volume":"196","author":"Coester","year":"2000","journal-title":"Int. J. Pharm."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X04007892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X04007892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T12:35:35Z","timestamp":1682685335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X04007892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0006291X04007892"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2004.04.067","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}